Home Home Home Inbox Home Search

Event

Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials [Board No. 412]

Location: Board no. 412
Session Type: RAPiD: Rapid Abstract Poster Discussion Session
Sunday
May
20
2:15 PM
4:15 PM

Speaker(s)/Author(s)

Frank Trudo

MD, MBA
AstraZeneca

Ubaldo J. Martin

MD
AstraZeneca

Ian Hirsch

PhD
AstraZeneca

Gokul Gopalan

MD,MPH
AstraZeneca

View Abstract

Impact of Body Mass Index on Efficacy of Benralizumab in Patients with Severe, Uncontrolled Eosinophilic Asthma: Pooled Analysis of the SIROCCO and CALIMA Trials

Parent Sessions

  • A101 - MECHANISMS AND CLINICAL FEATURES OF SEVERE ASTHMA...
    05-20-2018 2:15 PM - 4:15 PM
    • Home Home Home Inbox Home Search